about
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosisSite-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motifC2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane.Lysine acetylation targets protein complexes and co-regulates major cellular functionsGlobal, in vivo, and site-specific phosphorylation dynamics in signaling networks.Human Proteinpedia enables sharing of human protein dataProfiling the Trypanosoma cruzi phosphoproteome.Assessment of computational methods for predicting the effects of missense mutations in human cancersEvolutionary constraints of phosphorylation in eukaryotes, prokaryotes, and mitochondria.Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma.Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancerComprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomics.Large-scale proteomics analysis of the human kinome.Integrative analysis of two cell lines derived from a non-small-lung cancer patient--a panomics approach.A comprehensive transcriptional portrait of human cancer cell lines.Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network.Phosphoproteome analysis of the MAPK pathway reveals previously undetected feedback mechanisms.Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology.MAPU 2.0: high-accuracy proteomes mapped to genomes.Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers.Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancerCellular Interrogation: Exploiting Cell-to-Cell Variability to Discriminate Regulatory Mechanisms in Oscillatory Signalling.Uncovering a Dual Regulatory Role for Caspases During Endoplasmic Reticulum Stress-induced Cell Death.Systems-wide analysis of a phosphatase knock-down by quantitative proteomics and phosphoproteomics.Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors.Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle.Phosphoproteome of Pristionchus pacificus provides insights into architecture of signaling networks in nematode models.PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition.Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints.Stable isotope labeling by amino acids in cell culture (SILAC) applied to quantitative proteomics of Bacillus subtilis.High-accuracy identification and bioinformatic analysis of in vivo protein phosphorylation sites in yeast.Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.USP7 small-molecule inhibitors interfere with ubiquitin binding.The Ser/Thr/Tyr phosphoproteome of Lactococcus lactis IL1403 reveals multiply phosphorylated proteins.Phosphoproteome analysis of E. coli reveals evolutionary conservation of bacterial Ser/Thr/Tyr phosphorylation.Sebida: a database for the functional and evolutionary analysis of genes with sex-biased expression.
P50
Q24294864-CAEC759A-B640-4602-B16E-09A143FE5612Q24297572-A6CE21C1-20F8-4D24-8548-4BDDDA01B87FQ24337558-F701EB21-51BE-4D32-AA39-934F5B3E91A4Q27860589-F072D353-6CA2-4AFA-91DE-0FB72F2E682FQ27864128-53CC5EF3-75EE-4FED-B9E9-785CB938D955Q28267923-E775B3E8-1CA4-406A-8201-3026CBBF95A9Q34038289-D623A3AC-89D3-4CD3-9ADE-51A00528A965Q34790059-857719C5-4E20-4033-A1F0-4CE7AE447643Q35006547-89508F21-A151-4926-BC42-8E2AFBA12E12Q35674363-10EC6E43-C7D3-49BC-B257-7FAC96E903E8Q36321648-03D9FF6F-2E92-4096-94B8-5982FA0C11DFQ36446169-307C00B9-5F1C-4145-9545-16CE6312FCCAQ36515055-4B64B721-BB44-41A8-8140-91575313A741Q36568988-66899A84-45DE-4AE7-A122-3D40F94217DEQ37072842-CF971C3F-000E-49EE-8609-136358D6EE22Q37258113-DC3223CC-6427-4A82-BA5D-1F7F00D82D9EQ37613062-F475135E-84DB-45DE-B1BC-AC286071E80CQ37854720-FDA0E649-9D4A-4B2B-AC6C-E24D34A2F9A7Q38391539-E240BD30-2BFF-4AAC-B215-3CF38DA5804BQ38391612-CEB42E8D-3EB5-498A-8F8B-8F8A67BB072FQ38506649-1CEC08AA-88B6-4D7C-8E98-EF0B733729BFQ38512217-63AA3A6E-78BE-4770-87F9-458B062E469CQ38749629-C08034E2-0BB0-4094-AE1C-68F2688FD7E6Q38790079-EF5BACBB-2C5D-4446-A5A9-F1D5CF179497Q38997289-5D5DF73C-0F67-4544-8CC4-AE63FCE74FB7Q39639320-287CD8F5-9E86-4B28-9263-B001FB4F9B56Q39812677-031CABF8-00F4-44EB-A817-E904D9F97B89Q39853507-DCFB6255-65AD-46C3-B98C-D4E1BC31DB82Q39930538-6AEACA3A-98FC-49A1-80B2-3A427983574CQ41603456-E7300704-D703-4179-8E1D-770881DE6EDDQ41767316-48126800-C44A-4D1D-9AA7-E65DAD129111Q41994295-67668B39-3B67-4C55-9D32-9C5DC3E8F637Q43050786-EA603ADC-2D46-41AD-8703-0784EF4084A8Q43051533-2FF15E3E-FE73-4229-A01C-DD9F0CD59A85Q43268769-017C6EE6-6E0D-4863-A7F4-C7EE5DF4520FQ43474246-6535445D-D8BF-4286-9497-C447C7A4A563Q46429336-EAF5510D-0E76-43F9-A9BC-19FBA9CF3502Q46453903-554F65F6-4F37-4E8E-B935-1F72050FE738Q46949256-95D2F647-A6F4-47EC-9B6D-36837963A123Q48700465-15341D9F-1444-406F-8769-2ED09C20F593
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2287-2251
@en
name
Florian Gnad
@ast
Florian Gnad
@en
Florian Gnad
@es
Florian Gnad
@nl
type
label
Florian Gnad
@ast
Florian Gnad
@en
Florian Gnad
@es
Florian Gnad
@nl
prefLabel
Florian Gnad
@ast
Florian Gnad
@en
Florian Gnad
@es
Florian Gnad
@nl
P106
P21
P31
P496
0000-0002-2287-2251